Potential signatures of IDHWT recurrent tumour resistance included VUS that were possibly pathogenic in PTEN. PTEN mutations cause activation of the PI3K/AKT survival pathway and chemoresistance in GBM [80]. This evidence concerns the gene PIK3CA and neoplasm.